All News #Library
Sciences
FDA Clears IND for Ascletis` Oral GLP-1 ASC30 Phase II Trial
04 Jan 2026 //
PR NEWSWIRE
Oncology dominates a ‘Cambrian explosion’ in China’s drug pipeline
18 Mar 2019 //
ENDPTS
Ascletis, 3-V Biosciences Announce NASH Strategic License and Series E Financing
13 Feb 2019 //
PRESS RELEASE
Cancer-Testing Startup Backed by Bezos Weighs U.S. IPO Over Hong Kong
06 Dec 2018 //
BLOOMBERG

Market Place
Sourcing Support